Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01472094 · ClinicalTrials.gov registry record
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
A clinical trial of Breast Cancer, sponsored by City of Hope Medical Center.
- Active
- Registry status
- 700
- Enrollment target
- 17
- Study locations
NCT01472094: Active study of Breast Cancer, sponsored by City of Hope Medical Center.
NCT01472094 is a study of Breast Cancer that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 700 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (75% lower). The trial reports 17 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01472094, a study of Breast Cancer, is active but no longer recruiting, sponsored by City of Hope Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 17
- Study locations
Study Summary
The goal of this study is to develop a "bedside to bench" model of clinical and biological predictors for toxicity to adjuvant and neoadjuvant chemotherapy in older adults with breast cancer. The investigators will develop a predictive model using clinical and biological predictors of toxicity to adjuvant and neoadjuvant chemotherapy in older adults with breast cancer. The investigators will also determine the association between clinical and biological factors and reduced relative dose intensity of the prescribed chemotherapy regimen. In addition, the investigators will explore specific chemotherapy toxicities associated with reduced relative dose intensity of a prescribed regimen.
Conditions Studied
Study Locations (17)
New York
- Roswell Park Cancer Institute - Buffalo
- Hofstra-North-LIJ Cancer Institute - New Hyde Park
- Memorial Sloan-Kettering Cancer Center - New York
- University of Rochester Medical Center - Rochester
Massachusetts
- Massachusetts General Hospital - Boston
- Dana-Farber Cancer Institute - Boston
North Carolina
- University of North Carolina - Chapel Hill
- Wake Forest University - Winston-Salem
Pennsylvania
- Thomas Jefferson University - Philadelphia
- Fox Chase Cancer Center - Philadelphia
California
- City of Hope Medical Center - Duarte
Connecticut
- Yale University - New Haven
Illinois
- University of Chicago - Chicago
Missouri
- Washington University St. Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2011-09-09 |
| Est. Completion | 2026-09-18 |
What the registry record for NCT01472094 still lists
NCT01472094 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01472094 lists 17 locations in 11 states (New York, Massachusetts, North Carolina).
Frequently Asked Questions
What is clinical trial NCT01472094 about?
NCT01472094 is a clinical study titled "The Hurria Older PatiEnts (HOPE) With Breast Cancer Study". The goal of this study is to develop a "bedside to bench" model of clinical and biological predictors for toxicity to adjuvant and neoadjuvant chemotherapy in older adults with breast cancer. The investigators will develop a predictive model using clinical and biological predictors of toxicity to ad...
What is the current status of trial NCT01472094?
This trial is currently active not recruiting. The enrollment target is 700 participants. The study started on 2011-09-09. Estimated completion is 2026-09-18.
What conditions does trial NCT01472094 study?
This clinical trial studies the following conditions: Breast Cancer.
Who is sponsoring clinical trial NCT01472094?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01472094 being conducted?
This trial has 17 study locations across California, Connecticut, Illinois, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01472094's enrollment target sits among peer trials
700 161st of 1224 higher than 1,062 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI